![](/accounts/asam/images/printLogo.png)
Adulterants: Lessons in History and Current Trends
-
Register
- Non-Member - $39
- Regular Member - $29
- Retired - $29
- Early Career Physician - $29
- Resident - $19
- Student - $19
- Associate - $19
- ASAM Staff - Free!
- International Member - $29
- Emeritus Member - $29
- Provisional Member - $29
- Fellow Member - $29
- Honorary Member - $29
- CRT Member - $29
![Logo for ASAM's 55th Annual Conference Logo for ASAM's 55th Annual Conference](https://6ae8bbf0cbc766a02526-db9b3cfd1a1d7334c57f016ab97d9d02.ssl.cf2.rackcdn.com/asam_70ceb6b92b68066860e0a7e3801b0a2f.jpg)
Adulterants: Lessons in History and Current Trends
Recorded: Thursday, April 4, 2024 to Sunday, April 7, 2024
On-Demand Session
Overview
This 75-minute on-demand session from the ASAM 55th Annual Conference addresses the recent and historical trends in adulterants and contaminants including sulfonylureas, levamisole, local anesthetics, quinine, stimulants, opioids, brodifacoum, and alpha 2 agonists in the illicit drug supply.
This interactive didactic session with expert addiction medicine and medical toxicology faculty will discuss clinically relevant adulterants and contaminants in the illicit drug supply. Topics covered will include epidemiologic and pharmacologic aspects of adulterant xenobiotics. Issues regarding clinical and laboratory identification of common adulterants and contaminants will be identified.
The target audience for this Intermediate level session includes physicians, nurse practitioners, physician assistants, other clinicians, researchers, residents, fellows, students, and counselors.
This session addresses the following ACGME Competencies: Patient Care and Procedural Skills, Medical Knowledge
This session addresses the following ICPE Competencies:Roles and Responsibilities
Learning Objectives
Upon completion, learners will be able to:
- Describe the recent and historical trends in adulterants and contaminants including sulfonylureas, levamisole, local anesthetics, quinine, stimulants, opioids, brodifacoum, and alpha 2 agonists in the illicit drug supply.
- Explain the pharmacology and toxicology of common adulterants and contaminants in illicit drugs.
- Highlight current strategies for community-level recognition and mitigation of adulterants and contaminants in illicit drugs, including strategies for bedside clinical and laboratory identification.
Registration Rates
Rate Description | Rate |
ASAM Member | $29 |
Non-Member | $39 |
Associate Member | $19 |
Resident Member* | $19 |
Student Member* | $19 |
*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.
Membership Question? Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.
Refunds & Cancellations
All ASAM eLearning Center refund requests must be made in writing to education@asam.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or e-Learning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.
Registration Open: 05/06/2024 - 04/06/2027
User Access Closed: 05/06/2027
Session Instructions
- Click on the Contents tab to watch the on-demand recording.
- Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
- Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
- Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org
ASAM is proud to offer Essential Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.
![Speaker image](https://www.conferenceharvester.com/uploads/harvester/photos/cropKYVSYLGD-Presenter-SwartB.jpg)
Benjamin Swart, MD
Fellow Physician
University of Minnesota
Benjamin B. Swart, MD is an addiction medicine fellow at the University of Minnesota in Minneapolis, Minnesota. He completed his residency in internal medicine at Hennepin County Medical Center in Minneapolis, Minnesota as well as training in Clinical Tropical, Migrant, and Travel Medicine through the University of Minnesota's Department of Global Medicine. He holds a Certificate of Knowledge in Clinical Tropical Medicine and Travelers’ Health (CTropMed®) from the American Society of Tropical Medicine and Hygiene. His academic interests include addiction medicine in cross-cultural settings, khat addiction, and naloxone infusions. He lives in Minneapolis with his wife and three children.
![Speaker image](https://6ae8bbf0cbc766a02526-db9b3cfd1a1d7334c57f016ab97d9d02.ssl.cf2.rackcdn.com/asam_a92617e3b2f05f7bdcf5670b76740294.jpg)
JoAn Laes
MD
JoAn Laes, MD is an addiction medicine physician at Hennepin Healthcare in Minneapolis, Minnesota, focusing on inpatient addiction medicine and toxicology consultation as well as outpatient treatment of opioid and other substance use disorders. She is a core medical toxicology faculty for the Minnesota Poison Center, Minneapolis, Minnesota, medical director for Missions Inc. Detox facility in Plymouth, Minnesota and 1800 Chicago detox facility in Minneapolis, MN and a nocturnist at Mercy Hospital in Coon Rapids, Minnesota.
She is the chair of the medical toxicology workgroup for the American Society of Addiction Medicine and the president for the Minnesota chapter of ASAM. She completed internal medicine residency at Hennepin County Medical Center and medical toxicology fellowship at Regions Hospital in St. Paul, Minnesota and is board certified in Internal Medicine, Medical Toxicology, and Addiction Medicine.
![Speaker image](https://www.conferenceharvester.com/uploads/harvester/photos/cropKYVSYLGD-Presenter-SessionsD.jpg)
Daniel Sessions, MD, FACMT, FAAEM
Senior Lecturer
University of Queensland, Ochsner Clinical School
Dr. Daniel J Sessions MD is the Chief of the Division of Medical Toxicology at Ochsner Health Foundation. He is a senior lecturer in Emergency Medicine at the University of Queensland, Ochsner Clinical School in New Orleans, LA. He received his medical doctorate from the LSU-New Orleans School of Medicine. He was a Chief Resident in Emergency Medicine during his training at Brooke Army Medical Center in San Antonio, TX. He completed his medical toxicology fellowship at Rocky Mountain Poison & Drug Center at Denver Health.
After completing his training, Dr. Sessions returned to Brooke Army Medical Center where he served as the Director of Medical Toxicology. His Graduate Medical Education service included: Research Director of the Emergency Medicine Residency, Associate Program Director in Emergency Medicine, and Transitional Year Internship Associate Program Director. He served as a consulting toxicologist for the South Texas Poison Center, Army Substance Abuse Program, and Dept. of Defense ADVISOR system. After completion of his military service, he became board-certified in Addiction Medicine and practiced Addiction Medicine and Toxicology at Abbot Northwestern Hospital and Minnesota Poison Control in Minneapolis, MN.
He is currently a senior lecturer in Emergency Medicine at the University of Queensland, Ochsner Clinical School in New Orleans, LA, and part of the Emergency Medicine Residency Faculty. He provides Forensic Toxicology services through Expert Toxicology, LLC. His primary areas of interest are addiction medicine, envenomation, drug testing, and performance-enhancing drugs and supplements.
Accreditation & Credit Designation Statements
Joint Accreditation Statement
![image](https://6ae8bbf0cbc766a02526-db9b3cfd1a1d7334c57f016ab97d9d02.ssl.cf2.rackcdn.com/asam_a80a974b3d20c7cafe0aba912a44973a.png)
In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
The American Society of Addiction Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
This activity awards 1.25 Nursing contact hours.
![image image](https://6ae8bbf0cbc766a02526-db9b3cfd1a1d7334c57f016ab97d9d02.ssl.cf2.rackcdn.com/asam_5f934f962d27e479b1750ebcfeb0fce3.png)
PAs
ASAM has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 CME credits. Approval is valid until 05/06/2027. PAs should only claim credit commensurate with the extent of their participation.
Social Workers
As a Jointly Accredited Organization, ASAM is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.25 general continuing education credits.
IPCE Credit
This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credits for learning and change.
California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1225.
California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205.
California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1224.
Continuing Education Credits (CEUs)
Upon completion of the activity and online evaluation, all other participants may request a certificate of participation. Participants may submit this certificate of participation to their professional organization/institute as documentation for completing this accredited continuing activity.
Maintenance of Certification (MOC) or Continuing Certification Programs (CCP)
This activity meets the requirements for MOC/CCP for the following primary physician boards and for state licensing CME requirements. MOC Credit is only reported for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.
- American Board of Medical Specialties (ABMS)
- American Board of Preventive Medicine (ABPM)
- American Board of Internal Medicine (ABIM)
- American Board of Pediatrics (ABP)
- American Board of Surgery (ABS)
- American Board of Psychiatry and Neurology (ABPN)
- American Board of Addiction Medicine (ABAM)
- Royal College of Physicians and Surgeons of Canada (RCPSC)
- Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons in Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
Disclosure Information
In accordance with disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. These policies include mitigating all relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee members and Presenters have disclosed all financial relationship information. The ASAM CE Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity. Click here to view the full disclosure listing.
Key:
![](/images/product-status-icons/complete-small.png)
![](/images/product-status-icons/next-small.png)
![](/images/product-status-icons/disabled-small.png)
![](/images/product-status-icons/optional-small.png)
![](/images/product-status-icons/locked-small.png)